Skip to main content

Day: September 11, 2023

Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis

Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic pruritis BRIDGEWATER, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancer announces an exclusive option agreement to acquire a clinical stage asset, AV104, with a recently approved IND. AV104 has a dual mechanism of action by affecting multiple receptors, known to suppress chronic, debilitating pruritis or “uncontrollable itching”. The Company intends to first...

Continue reading

Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split

The combined company will operate as “Dianthus Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “DNTH” effective Tuesday, September 12, 2023 CAMBRIDGE, Mass., Sept. 11, 2023 (GLOBE NEWSWIRE) — Magenta Therapeutics, Inc. (Nasdaq: MGTA) (“Magenta”) today announced completion of the merger with Dianthus Therapeutics, Inc. (“Dianthus”) following Magenta’s successful receipt of stockholder approval for all proposals related to the merger at a special meeting of stockholders. Magenta effected a reverse stock split of Magenta’s common stock immediately prior to the merger. Magenta following the merger is referred to herein as the “combined company.” Steve Mahoney, President and Chief Financial and Operating Officer of Magenta said, “We are pleased with the outcome of the special meeting and appreciate our...

Continue reading

Forward Solutions Announces the Merger of George W. Mouk & Associates into Avision

HERSHEY, Pa., Sept. 11, 2023 (GLOBE NEWSWIRE) — Forward Solutions, a leading provider of outsources sales and marketing, is excited to announce the successful merger of George W. Mouk & Associates and Avision. This strategic collaboration marks a significant step towards enhancing service offerings and increasing market presence. George W. Mouk & Associates has been a leader in the foodservice and janitorial channel, serving customers in Louisiana, Mississippi, Arkansas, West Tennessee, Southern Alabama, and the Florida panhandle since 1970. Lee Mouk, President of George W. Mouk & Associates, shared his anticipation about this merger, stating, “I look forward to being part of a team of professional sales reps and the increased ability to serve our manufacturer and distributor partners.” This strategic...

Continue reading

Mullen Acquires Battery Pack Production Assets From Romeo Power

Assets purchased for approximately $3.5M includes equipment, inventory and IP for high volume EV battery pack production BREA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces the purchase of battery pack production assets from Romeo Power for approximately $3.5 million. The deal includes equipment, inventory and intellectual property for high volume EV (electric vehicle) battery pack and module production. The Romeo Power assets include production lines for EV pack assembly and precision R&D module and pack development with associated inventory allowing for production of modules and vehicle battery packs. Additionally the purchased assets include battery testing and validation equipment,...

Continue reading

Global Lyme Disease Treatment Market Size to Reach USD 1,826.3 Million in 2032 | Emergen Research

Increase in the number of Lyme disease cases across the globe is a key factor driving market revenue growth Vancouver, Sept. 11, 2023 (GLOBE NEWSWIRE) — The global Lyme disease treatment market size was USD Million 850.0 in 2022 and is expected to register a revenue CAGR of 8.5% during the forecast period, according to latest analysis by Emergen Research. Increasing investment by major companies and rising development in healthcare facilities and diagnostic procedures across the globe are projected to support revenue growth of the Lyme disease treatment market during the forecast period. For both people and animals suspected of having been in touch with the disease, the greater accuracy of Spectroscopic testing may improve diagnosis procedures for Lyme disease. The new test could benefit mobile veterinary services for animals...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.